Skip to main content
. 2020 Jan 21;37(3):525–542. doi: 10.1007/s12640-020-00164-6

Fig. 7.

Fig. 7

The effect of combined treatment with necrostatin-1 (Nec-1) and pan-caspase inhibitor (Z-VAD-fmk) against the H2O2- (a) and glutamate- (Glu, b) induced cell damage in HT-22 cells. The cells were pre-treated for 30 min with Nec-1 (20 μM) and Z-VAD-fmk (20 μM) alone or in combination followed by 24 h of treatment with H2O2 (1 mM) or Glu (3 mM). Cell viability was estimated by the MTT reduction assay, and data were normalized to vehicle-treated cells (control) and are presented as the mean ± SEM from 3 to 7 separate experiments with 5 repetitions each. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. vehicle-treated cells; #P < 0.05 and ###P < 0.001 vs. H2O2- or Glu-treated cells; &P < 0.05 and &&&P < 0.001 vs. H2O2 + Nec-1 or Glu + Nec-1-treated cells